Doors unlocked to Tamiflu trial data

After years of campaigning, the Cochrane Collaboration will finally be given access to all of Roche's clinical trials on oseltamivir (Tamiflu), the BMJ has revealed.

The pharmaceutical giant has reportedly told Cochrane researchers it will provide detailed reports over the next few months for all 74 trials the company sponsored on the under-fire flu drug.

The two parties have been in talks for over three years about sharing the data — escalating into a public row last January when Cochrane went ahead and published an unflattering